MARKET

NTRA

NTRA

Natera Inc
NASDAQ
92.35
+3.74
+4.22%
Opening 10:22 04/23 EDT
OPEN
--
PREV CLOSE
88.61
HIGH
92.45
LOW
--
VOLUME
104.80K
TURNOVER
--
52 WEEK HIGH
98.82
52 WEEK LOW
36.90
MARKET CAP
11.15B
P/E (TTM)
-24.4248
1D
5D
1M
3M
1Y
5Y
First Week of June 21st Options Trading For Natera (NTRA)
NASDAQ · 1d ago
Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications Highlighting Natera's Technology In The Scientific Literature.
Demonstrates commitment to generating real-world clinical evidence to change disease management and improve patient outcomes. More than 200 peer-reviewed papers highlighting Natera's technology in the scientific literature. Landmark cutting-edge science and clinical trial data based on NaterA's suite of products have been published in top journals.
Benzinga · 1d ago
Weekly Report: what happened at NTRA last week (0415-0419)?
Weekly Report · 1d ago
NATERA INC <NTRA.O>: TD COWEN RAISES TARGET PRICE TO $123 FROM $110
Reuters · 6d ago
TipRanks’ ‘Perfect 10’ List: Analysts See Opportunity in These 2 Top-Scoring Stocks
TipRanks · 6d ago
U.S. RESEARCH ROUNDUP-3M, J&J, Nuvalent
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. 3M, J&J and Nuvalent are among the companies. Analysts also raise their targets on Amazon, Tractor Supply, UnitedHealth Group and Amgen. NEW: 3M cuts its target price to $110 from $118; 10X Genomics cuts target price.
Reuters · 6d ago
U.S. RESEARCH ROUNDUP-Advanced Micro Devices, Kroger, Tyson Foods
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Advanced Micro Devices, Kroger and Tyson Foods among companies with new targets. Analysts raise ratings and target prices on several companies. Boeing, Caterpillar and AIG among those with targets raised.
Reuters · 04/16 07:18
Natera Is Maintained at Buy by Goldman Sachs
Dow Jones · 04/15 14:38
More
About NTRA
Natera, Inc. is a diagnostics company, which is focused on the development and commercialization of molecular testing services, applying its technology in the fields of women’s health, oncology and organ health. Its cell-free deoxyribonucleic acid (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The Company's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening, Spectrum Preimplantation Genetics, Anora Miscarriage Test, Empower, and Prospera. The Company also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Company’s algorithms and bioinformatics in order to validate and launch tests based on the Company’s technology. Its NIPT screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother.

Webull offers Natera Inc stock information, including NASDAQ: NTRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTRA stock methods without spending real money on the virtual paper trading platform.